Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122759724 | 12275972 | 4 | F | 201203 | 20160706 | 20160418 | 20160711 | EXP | PHJP2016JP009092 | NOVARTIS | 63.76 | YR | M | Y | 0.00000 | 20160711 | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122759724 | 12275972 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 300 MG, BID | 90600 | MG | Y | 22068 | 300 | MG | CAPSULE | BID | |||
| 122759724 | 12275972 | 2 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 500 MG, QD | 0 | 500 | MG | QD | |||||||
| 122759724 | 12275972 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 750 MG, UNK | 0 | 750 | MG | ||||||||
| 122759724 | 12275972 | 4 | C | SITAGLIPTIN | SITAGLIPTIN | 1 | Unknown | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 122759724 | 12275972 | 5 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | 100 MG, QD | 0 | 100 | MG | TABLET | QD | ||||||
| 122759724 | 12275972 | 6 | C | ADALAT | NIFEDIPINE | 1 | Oral | 20 MG, QD | Y | 0 | 20 | MG | TABLET | QD | |||||
| 122759724 | 12275972 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | TABLET | QD | ||||||
| 122759724 | 12275972 | 8 | C | WARFARIN | WARFARIN | 1 | Oral | 2 MG, QD | Y | 0 | 2 | MG | TABLET | QD | |||||
| 122759724 | 12275972 | 9 | C | ARTIST | CARVEDILOL | 1 | Oral | 2.5 MG, QD | 0 | 2.5 | MG | TABLET | QD | ||||||
| 122759724 | 12275972 | 10 | C | DIOVAN | VALSARTAN | 1 | Oral | 80 MG, QD | 0 | 80 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122759724 | 12275972 | 1 | Chronic myeloid leukaemia |
| 122759724 | 12275972 | 2 | Product used for unknown indication |
| 122759724 | 12275972 | 4 | Product used for unknown indication |
| 122759724 | 12275972 | 5 | Product used for unknown indication |
| 122759724 | 12275972 | 6 | Product used for unknown indication |
| 122759724 | 12275972 | 7 | Product used for unknown indication |
| 122759724 | 12275972 | 8 | Product used for unknown indication |
| 122759724 | 12275972 | 9 | Product used for unknown indication |
| 122759724 | 12275972 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122759724 | 12275972 | OT |
| 122759724 | 12275972 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122759724 | 12275972 | Abdominal pain upper | |
| 122759724 | 12275972 | Cholangitis acute | |
| 122759724 | 12275972 | Diabetes mellitus | |
| 122759724 | 12275972 | Diabetes mellitus inadequate control | |
| 122759724 | 12275972 | Dyspnoea | |
| 122759724 | 12275972 | Palpitations | |
| 122759724 | 12275972 | Platelet count decreased | |
| 122759724 | 12275972 | Vascular stent stenosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122759724 | 12275972 | 1 | 20120115 | 20160208 | 0 | |
| 122759724 | 12275972 | 2 | 201211 | 201411 | 0 | |
| 122759724 | 12275972 | 3 | 201411 | 0 | ||
| 122759724 | 12275972 | 4 | 201502 | 0 | ||
| 122759724 | 12275972 | 6 | 20120506 | 0 | ||
| 122759724 | 12275972 | 8 | 20120408 | 0 |